Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-11-15 Sale(A) |
2025-02-28 6:54 pm |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
43,216 | $4.9925 | $215,754 | 167,522 (Direct) |
View |
2024-11-15 Sale |
2024-11-20 08:23 am |
Skye Bioscience Inc. | SKYE | Diep Tuan Tu Chief Development Officer |
19,574 | $4.9924 | $97,722 | 82,259 (Direct) |
View |
2024-11-15 Sale |
2024-11-19 9:57 pm |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
43,396 | $4.9925 | $216,652 | 166,342 (Direct) |
View |
2024-11-15 Sale |
2024-11-19 9:20 pm |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
82,910 | $4.9925 | $413,925 | 339,166 (Indirect Direct) |
View |
2024-11-15 Sale |
2024-11-19 9:14 pm |
Skye Bioscience Inc. | SKYE | Grayson Paul A. Director |
86,551 | $4.992 | $432,061 | 259,701 (Direct) |
View |
2024-09-11 Sale |
2024-09-13 6:56 pm |
Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner |
266,337 | $6.5719 | $1,750,352 | 66,277 (Indirect) |
View |
2024-09-11 Sale |
2024-09-13 6:54 pm |
Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner |
266,337 | $6.5719 | $1,750,352 | 66,277 (Indirect) |
View |
2024-03-13 Purchase |
2024-03-15 4:15 pm |
Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner |
450,000 | $10 | $4,500,000 | 10,179,505 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-24 Option Award |
2025-02-26 7:45 pm |
N/A 2035-02-25 |
Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director |
35,000 | $0 | 35,000 (Direct) |
View |
2025-02-24 Option Award |
2025-02-26 5:53 pm |
N/A 2035-02-25 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
2025-02-24 Option Award |
2025-02-26 5:51 pm |
N/A 2035-02-25 |
Skye Bioscience Inc. | SKYE | Jenkins Annalisa Director |
35,000 | $0 | 35,000 (Direct) |
View |
2025-02-24 Option Award |
2025-02-26 5:47 pm |
N/A 2035-02-25 |
Skye Bioscience Inc. | SKYE | Grayson Paul A. Director |
135,000 | $0 | 135,000 (Direct) |
View |
2025-02-24 Option Award |
2025-02-26 5:45 pm |
N/A 2035-02-25 |
Skye Bioscience Inc. | SKYE | Smith Karen L. Director |
35,000 | $0 | 35,000 (Direct) |
View |
2025-02-24 Option Award |
2025-02-26 5:43 pm |
N/A 2035-02-25 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
250,000 | $0 | 250,000 (Direct) |
View |
2025-02-24 Option Award |
2025-02-26 5:41 pm |
N/A 2035-02-25 |
Skye Bioscience Inc. | SKYE | Charych Deborah H. Director |
35,000 | $0 | 35,000 (Direct) |
View |
2025-02-24 Option Award |
2025-02-26 5:38 pm |
N/A 2035-02-25 |
Skye Bioscience Inc. | SKYE | Diep Tuan Tu Chief Development Officer |
150,000 | $0 | 150,000 (Direct) |
View |
2025-02-24 Option Award |
2025-02-26 5:34 pm |
N/A 2035-02-25 |
Skye Bioscience Inc. | SKYE | Arora Puneet S. Chief Medical Officer |
38,000 | $0 | 38,000 (Direct) |
View |
2024-10-28 Option Award |
2024-10-30 8:33 pm |
N/A 2034-10-27 |
Skye Bioscience Inc. | SKYE | Diep Tuan Tu Chief Development Officer |
125,000 | $0 | 125,000 (Direct) |
View |
2024-10-28 Option Award |
2024-10-30 8:32 pm |
N/A 2034-10-27 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
2024-10-28 Option Award |
2024-10-30 8:31 pm |
N/A 2034-10-27 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
650,000 | $0 | 650,000 (Direct) |
View |
2024-10-28 Option Award |
2024-10-30 8:30 pm |
N/A 2034-10-27 |
Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director |
70,000 | $0 | 70,000 (Direct) |
View |
2024-10-28 Option Award |
2024-10-30 8:29 pm |
N/A 2034-10-27 |
Skye Bioscience Inc. | SKYE | Grayson Paul A. Director |
70,000 | $0 | 70,000 (Direct) |
View |
2024-10-28 Option Award |
2024-10-30 8:28 pm |
N/A 2034-10-27 |
Skye Bioscience Inc. | SKYE | Smith Karen L. Director |
70,000 | $0 | 70,000 (Direct) |
View |
2024-10-28 Option Award |
2024-10-30 8:25 pm |
N/A 2034-10-27 |
Skye Bioscience Inc. | SKYE | Charych Deborah H. Director |
70,000 | $0 | 70,000 (Direct) |
View |
2024-10-28 Option Award |
2024-10-30 8:25 pm |
N/A 2034-10-27 |
Skye Bioscience Inc. | SKYE | Jenkins Annalisa Director |
70,000 | $0 | 70,000 (Direct) |
View |
2024-09-03 Option Award |
2024-09-04 6:12 pm |
N/A 2034-09-03 |
Skye Bioscience Inc. | SKYE | Arora Puneet S. Chief Medical Officer |
225,000 | $0 | 225,000 (Direct) |
View |
2024-08-26 Other |
2024-08-27 5:20 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
15,727 | $0 | 437,803 (Direct) |
View |
2024-07-02 Option Award |
2024-07-05 08:59 am |
N/A 2034-07-01 |
Skye Bioscience Inc. | SKYE | Smith Karen L. Director |
40,000 | $0 | 40,000 (Direct) |
View |
2024-03-13 Option Award |
2024-03-15 4:15 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner |
450,000 | $10 | 10,179,505 (Indirect) |
View |
2024-02-29 Option Award |
2024-03-04 7:53 pm |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | Grayson Paul A. Director |
135,000 | $0 | 381,252 (Direct) |
View |
2024-02-29 Option Award |
2024-03-04 6:02 pm |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | Charych Deborah H. Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-02-29 Option Award |
2024-03-04 6:01 pm |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | Jenkins Annalisa Director |
40,000 | $0 | 40,000 (Direct) |
View |
2024-02-29 Option Award |
2024-03-04 4:04 pm |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-02-29 Option Award |
2024-03-04 06:24 am |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | DALESANDRO MARGARET Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-02-29 Option Award |
2024-03-04 06:23 am |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | Ward Keith Wayne Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-02-29 Option Award |
2024-03-04 06:20 am |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-02-29 Option Award |
2024-03-04 06:19 am |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | Diep Tuan Tu Chief Development Officer |
100,000 | $0 | 176,833 (Direct) |
View |